Institutional investors hold a majority ownership of TEVA through the 59.64% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2016, these large investors purchased a net $5.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB ... Bought 1.1 Million shares of Teva Pharmaceutical